Latest From Rheonix Inc.
The global molecular diagnostics market will grow by $2.4 billion over the next five years according to a global market report from Medtech Insight. Major factors contributing to the healthy growth of this market include advances in technology, as well as the growing understanding of the human genome, pharmacogenomics and the relationship between genes and disease/infection.
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
- Nanotechnology, Chips, etc.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Medical Devices
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Infectious & Viral Diseases
- North America
- Parent & Subsidiaries
- Rheonix Inc.
- Senior Management
Tony Eisenhut, Pres. & CEO
Peng Zhou, PhD, SVP, R&D & CSO
Richard A Montagna, SVP, Corp. Bus. Dev. & Scientific Affairs
- Contact Info
Phone: (607) 257-1242
22 Thornwood Dr.
Ithaca, NY 14850
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.